Henry Schein (NASDAQ:HSIC) Sets New 1-Year Low - Time to Sell?

Henry Schein, Inc. (NASDAQ:HSIC - Get Free Report)'s stock price hit a new 52-week low during trading on Thursday . The company traded as low as $60.56 and last traded at $66.16, with a volume of 2805215 shares traded. The stock had previously closed at $62.70.

Wall Street Analysts Forecast Growth

A number of analysts recently issued reports on HSIC shares. StockNews.com upgraded Henry Schein from a "hold" rating to a "buy" rating in a report on Wednesday, April 9th. Bank of America upgraded Henry Schein from an "underperform" rating to a "buy" rating and raised their price target for the company from $69.00 to $84.00 in a research note on Monday, January 6th. Jefferies Financial Group increased their target price on shares of Henry Schein from $77.00 to $80.00 and gave the stock a "hold" rating in a report on Thursday, January 23rd. Wells Fargo & Company began coverage on shares of Henry Schein in a research report on Friday, February 14th. They set an "equal weight" rating and a $80.00 target price on the stock. Finally, Barrington Research reaffirmed an "outperform" rating and issued a $90.00 price target on shares of Henry Schein in a research report on Wednesday, February 26th. Five investment analysts have rated the stock with a hold rating, six have given a buy rating and one has given a strong buy rating to the company. According to MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $81.10.

Henry Schein Stock Performance

The business has a 50-day moving average price of $71.58 and a 200-day moving average price of $72.19. The company has a quick ratio of 0.82, a current ratio of 1.42 and a debt-to-equity ratio of 0.46. The firm has a market capitalization of $7.99 billion, a price-to-earnings ratio of 26.46, a P/E/G ratio of 2.13 and a beta of 0.84.

Henry Schein (NASDAQ:HSIC - Get Free Report) last announced its earnings results on Tuesday, February 25th. The company reported $1.19 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.23 by ($0.04). The business had revenue of $3.19 billion for the quarter, compared to analyst estimates of $3.25 billion. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The company's quarterly revenue was up 5.8% on a year-over-year basis. During the same period in the prior year, the company earned $0.66 earnings per share. As a group, sell-side analysts forecast that Henry Schein, Inc. will post 4.74 earnings per share for the current year.

Insider Activity at Henry Schein

In related news, Director Philip A. Laskawy sold 2,604 shares of Henry Schein stock in a transaction dated Wednesday, March 19th. The stock was sold at an average price of $71.04, for a total transaction of $184,988.16. Following the completion of the sale, the director now owns 24,805 shares of the company's stock, valued at $1,762,147.20. The trade was a 9.50 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO Bradford C. Connett sold 4,036 shares of the company's stock in a transaction that occurred on Wednesday, March 19th. The shares were sold at an average price of $71.15, for a total value of $287,161.40. Following the completion of the sale, the chief executive officer now owns 62,688 shares in the company, valued at approximately $4,460,251.20. This represents a 6.05 % decrease in their position. The disclosure for this sale can be found here. 1.14% of the stock is currently owned by insiders.

Institutional Trading of Henry Schein

Several institutional investors and hedge funds have recently bought and sold shares of HSIC. Versant Capital Management Inc boosted its holdings in Henry Schein by 274.6% in the fourth quarter. Versant Capital Management Inc now owns 457 shares of the company's stock valued at $32,000 after purchasing an additional 335 shares during the last quarter. Investment Management Corp VA ADV acquired a new stake in Henry Schein in the 4th quarter valued at $32,000. Venturi Wealth Management LLC increased its holdings in Henry Schein by 3,347.1% in the 4th quarter. Venturi Wealth Management LLC now owns 586 shares of the company's stock worth $41,000 after acquiring an additional 569 shares in the last quarter. Quent Capital LLC grew its position in shares of Henry Schein by 91.2% in the fourth quarter. Quent Capital LLC now owns 677 shares of the company's stock valued at $47,000 after purchasing an additional 323 shares during the period. Finally, Smartleaf Asset Management LLC raised its position in shares of Henry Schein by 23.2% during the 4th quarter. Smartleaf Asset Management LLC now owns 759 shares of the company's stock worth $52,000 after purchasing an additional 143 shares during the last quarter. 96.62% of the stock is currently owned by institutional investors and hedge funds.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.